HSBC analyst Sezgi Oezener initiated coverage of GE HealthCare with a Buy rating and $100 price target. The analyst sees room for the company to drive margin expansion in imaging and deepen service income. The firm likes GE HealthCare’s risk/reward balance, and sees potential upside from the company’s stepped up efforts in artificial intelligence and innovation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GEHC:
- Rivian downgraded, Loweâs upgraded: Wall Street’s top analyst calls
- GE HealthCare upgraded to Neutral from Sell at UBS
- GE HealthCare, Medquest enter three-year collaboration
- GE HealthCare price target raised to $93 from $86 at Evercore ISI
- GE HealthCare price target raised to $94 from $84 at Piper Sandler
